Sanity G6 NPWT pump rental is a negative pressure wound therapy pump, and does not use an internal air pump to provide vacuum to a collection canister. The Sanity G6 instead has a patented vacuum pump that is integrated with a canister.
The tubing is permanently attached and a venting system keeps the tubing clear.
The pump is FDA-listed and PDAC-approved. It can run for up to 30 hours.
It can be used with Nurse Rosie’s GelTex NPWT Black Foam Kits, LipoGel or IodoFoam.
WiseGuyReports.com adds “Negative Pressure Wound Therapy – Medical Devices Pipeline Assessment 2016” report to its research database.
GlobalData’s Medical Devices sector report, “Negative Pressure Wound Therapy (NPWT) – Medical Devices Pipeline Assessment, 2016″ provides an overview of Negative Pressure Wound Therapy (NPWT) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Negative Pressure Wound Therapy (NPWT) pipeline products.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Complete report in Detailed @ https://www.wiseguyreports.com/reports/negative-pressure-wound-therapy-npwt-medical-devices-pipeline-assessment-2016
– Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Negative Pressure Wound Therapy (NPWT) and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to buy
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Negative Pressure Wound Therapy (NPWT) under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Order a Purchase Report Copy @ https://www.wiseguyreports.com/check_discount/negative-pressure-wound-therapy-npwt-medical-devices-pipeline-assessment-2016
Table of Content :
1.1 List of Tables
Table 1: Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Stage of Development 5
Table 2: Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Territory 6
Table 3: Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Regulatory Path 7
Table 4: Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Estimated Approval Date 8
Table 5: Negative Pressure Wound Therapy (NPWT) Companies – Pipeline Products by Stage of Development 9
Table 6: Negative Pressure Wound Therapy (NPWT) – Pipeline Products by Stage of Development 10
Table 7: Adept Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 11
Table 8: Wound Pressure Device – Product Status 11
Table 9: Wound Pressure Device – Product Description 11
Table 10: Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 12
Table 11: Next Generation Negative Pressure Wound Therapy Device – Product Status 12
Table 12: Next Generation Negative Pressure Wound Therapy Device – Product Description 12
Table 13: Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview 13
Table 14: Negative-Pressure Wound Therapy System – Product Status 14
Table 15: Negative-Pressure Wound Therapy System – Product Description 14
Table 16: LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 15
Table 17: Negative Pressure Wound Care Device – Product Status 15
Table 18: Negative Pressure Wound Care Device – Product Description 15
Table 19: Montana State University Pipeline Products & Ongoing Clinical Trials Overview 16
Table 20: Tissue Cooling Negative Pressure Wound Therapy System – Product Status 17
Table 21: Tissue Cooling Negative Pressure Wound Therapy System – Product Description 17
Table 22: Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview 18
Table 23: ShieldHeart Protection Device – Product Status 18
Table 24: ShieldHeart Protection Device – Product Description 18
Table 25: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 26: RENASYS 3 – Product Status 20
Table 27: RENASYS 3 – Product Description 20
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
| San Antonio
Thursday, April 14, 2016, 17:00 Hrs [IST]
Acelity, a global advanced wound care and regenerative medicine company, announced that its TIELLE Foam Dressing Family is now available in the United States. The TIELLE Dressing Family expands the industry-leading advanced wound therapeutics portfolio from Acelity. This expansion complements a broad range of existing solutions for chronic and acute wounds and provides clinicians with efficient and cost-effective options for treating patients.
The company announced the availability of these products at the joint meeting of the Symposium of Advanced Wound Care and the Wound Healing Society (SAWC Spring/WHS) in Atlanta.
“Our goal was to reinvigorate the range of proven TIELLE Dressings and introduce it to clinicians here in the US who are seeking effective solutions for all patients, including the most compromised,” said Joe Woody, president and chief executive officer of Acelity. “We aim to strengthen our partnership with nurses and physicians by broadening our platform to include an extensive range of dressings, advancements in negative pressure technology and new innovations designed to help speed healing for patients and reduce the overall cost of care.”
The TIELLE Foam Dressing Family was designed to meet the needs of healthcare professionals, including exudate management and reduced pain for the patient at dressing removal.
The TIELLE Hydropolymer Dressings – TIELLE Silicone Border and TIELLE Non-Adhesive – include the unique LIQUALOCK Advanced Absorption Technology which locks fluid away to help prevent leakage and maceration. Both dressings are intended to manage a range of exudate levels in partial or full thickness wounds. They are designed to help maintain a moist wound healing environment through the combination of fluid absorption and moisture vapor transfer rate (MVTR), and to be worn for up to seven days depending on the wound condition and exudate levels, which may help reduce the number of dressing changes and associated cost, a benefit for patients, payors and providers.
TIELLE Silicone Border is intended to manage a range of exudate levels in partial or full thickness wounds. The soft silicone adhesive spans the full extent of the dressing, allowing for gentle removal, helping to minimise pain and trauma for the patient.
TIELLE Non-Adhesive is a low profile dressing, which supports patient comfort and may be cut to size.
TIELLE ESSENTIAL Foam Dressings provide a range of economical foam dressings designed to absorb moderate to heavy exudate, maintaining a moist healing environment to aid in the healing process for chronic and acute wounds. The range of new available dressings includes: TIELLE ESSENTIAL Non-Adhesive and Heel; TIELLE ESSENTIAL Border; TIELLE ESSENTIAL Silicone Border; TIELLE ESSENTIAL Silicone Border Sacrum; TIELLE ESSENTIAL Silicone
“Acelity will continue to strengthen our portfolio of wound care and regenerative medicine products to provide clinicians the most options at every step of the care continuum – from the O.R., to the hospital room and at home,” said Woody.
Systagenix, an Acelity company, introduced the TIELLE Hydropolymer Dressing range in Europe in 1992. In 2013, KCI commercialised Negative Pressure Wound Therapy with the introduction of the V.A.C. Therapy System in 1995 and then strengthened its position in the global wound therapeutics industry by acquiring Systagenix in 2012, increasing the company’s ability to offer best-in-class products across the wound care continuum. In 2014, KCI, Systagenix, and LifeCell, a developer of tissue repair products, combined to form Acelity, a global corporation devoted to the art and science of healing.
Simplified negative pressure wound therapy systems can provide healing results comparable to more complex systems, a new study shows.
Some advanced NPWT Rental systems are too complex for routine use and are not cost- effective for many healthcare providers, according to investigators from Brazil’s Bahia State General Hospital.
Researchers treated patients with difficult-to-manage wounds using a “simplified” NPWT REntal system that’s quieter, easier to use and more widely available than the “gold standard” systems, they said.
Healing of the wounds treated with the simplified system was found to be satisfactory in 87% of the cases, and had low complication rates.
Those results show promise for healthcare facilities with limited resources or fewer trained staff members, researchers said.
In addition to positive healing outcomes, the simplified system also saved money. Typical NPWT rental costs range from $700 to $3,450 per patient each week, while the simplified system cost around $390 per person each week and $174 for each vacuum dressing.
Results of the study appear in the February issue of Wounds.
“Negative Pressure Wound Therapy (NPWT) Global 2016 Clinical Trials Review, ” provides an detailed overview of Negative Pressure Wound Therapy (NPWT) scenario.
Report includes top line data relating on Negative Pressure Wound Therapy (NPWT Rental) Global clinical trials scenario.
This report on Negative Pressure Wound Therapy (NPWT) also includes an review of trial numbers as well as their ( Negative Pressure Wound Therapy (NPWT) ) average enrollment in uppermost/top countries which are conducted worldwide.
Negative Pressure Wound Therapy (NPWT) report also covers disease clinical trials by country (G7 & E7), sponsor type, region, trial status as well as end points status.
Report Negative Pressure Wound Therapy (NPWT) also Includes prominent drugs for in-progress trials (Note: based on number of ongoing trials).
Scope of Negative Pressure Wound Therapy (NPWT) Report:-
1. This report includes a snapshot of worldwide clinical trials landscape on Negative Pressure Wound Therapy (NPWT) scenario.
2. Report on Negative Pressure Wound Therapy (NPWT) also provides top level data related to the Global clinical trials by country (G7 & E7), sponsor type, region, trial status as well as end points status on Negative Pressure Wound Therapy (NPWT) scenario
3. Report reviews top companies involved in Negative Pressure Wound Therapy (NPWT) as well as provides enlists all trials (Trial title, Phase, and Status) pertaining to the company on Negative Pressure Wound Therapy (NPWT) scenario.
4. This report provides all the unaccomplished trials on Negative Pressure Wound Therapy (NPWT) scenario (Withdrawn, Terminated and Suspended) with reason for unaccomplishment on Negative Pressure Wound Therapy (NPWT) .
5. Report on Negative Pressure Wound Therapy (NPWT) provides enrollment trends for the past five years.
6. Report provides latest news for the past three months
7. Report Also Includes Top news in past 3 months on Negative Pressure Wound Therapy (NPWT) clinical trials review scenario.
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.
Ethicon, 3M, Covidien and Various Local Manufacturers Compete in Growing Indian Wound and Tissue Management Market
In 2015, the Tissue Sealant Market Exhibited the Highest Growth Rates in India; This Market Includes Fibrin, Protein-Based and Synthetic Tissue Sealants From Ethicon, Baxter and Reliance Life Science
VANCOUVER, BC–(Marketwired – March 31, 2016) – According to a new series of reports on the Indian market for wound and tissue management by iData Research (www.idataresearch.com), India has been rapidly adopting more advanced technologies for wound care. As surgeons and hospitals become aware of the increased benefits and long-term cost savings associated with anti-adhesion and tissue sealant products, the adoption rates will rise. Each of the advanced dressing markets is expected to grow rapidly over the forecast period. As a result, these markets will represent a larger proportion of the total wound management market by 2022.
In contrast, traditional wound care techniques and many other wound closure devices are very well-known to healthcare professionals in India. Increasing numbers of laparoscopic procedures has resulted in growing demand for the premium-priced endoscopic staplers, which has significantly contributed to the growth of the wound closure market. These products are generally less expensive than more advanced wound care products, which will contribute to continued customer demand. Therefore wherever possible, traditional dressings are preferred over the expensive moist and antimicrobial dressings, especially since there is no reimbursement for advanced wound dressings in India.
READ MORE HERE
Pronto is a patented customer notification application for durable medical equipment companies that are currently have NPWT rentals in their inventory portfolio.
Email reminders are the quickest way to connect with your customers, to provide your customer notice, that there are only two wound dressings left in their inventory.
Click Here To Learn More
INNOVATIVE TECHNOLOGY GIVING CUSTOMERS AN ADDITIONAL SAFEGUARD ON NPWT REFILLS .
Smithfield, RI, March 22,2016
Equinox Medical Introduces Pronto a Customer Notification Application to Help Bring NPWT Dealers and Their Customers Equinox Medical, LLC, developer of negative pressure wound therapy (NPWT) foam dressings, NPWT pump systems and NPWT advanced software, announced today that it will officially launch Pronto: Customer Notification Application. Pronto is a software application that was designed to help a NPWT dealer and their customers communicate via email. The automated email software application was created and designed to help bring a new way to communicate with every customer using NPWT products. This refill ordering process is easier and much more efficient. Pronto, will send an email reminder to any customer, who only has 2 foam dressing kits left in their inventory.
Pronto’s Features and Benefits:
Pronto can be used by every clinician and NPWT dealer. It can be accessed via internet thru and encrypted HIPPA compliant server. The application is a proactive approach in providing a high tech communication solution to every NPWT dealer and their customers. Pronto is being offered for a 30 days FREE Trial. For more product information, please visit Pronto Application or Free Webinar
|EQUINOX MEDICAL, LLC|
|About EquinoxO2 Medical, LLC Equinoxo2 Medical, LLC, headquartered in Smithfield, RI is a privately held medical device company focused on the development of advanced wound healing technology. Equinox is dedicated to developing and designing innovative wound care products that are cost effective and delivers significant clinical outcomes. Our goal and strategy is to improve a patient’s quality of life. Our passion and dedication is to provide a better solution in repairing and healing the human body. For more information, please visit www.equinoxo2.com. Media Contact Gary Schear, Vice President of International and USA Sales Telephone: 800-504-3150 Ext 104 Email: Gary@equinoxo2.com|
Vice President of International and USA Sales
Telephone: 800-504-3150 Ext 104